Skip to main content
. 2021 Oct;16(10):1705–1717. doi: 10.1016/j.jtho.2021.05.018

Figure 1.

Figure 1

Study flowchart summarizing patient recruitment, sample selection for assay cohorts, diagnosis and assay QC steps including reasons for exclusion from the final analysis, and disease group memberships. AEC, asbestos-exposed control; MPM, Malignant pleural mesothelioma; QC, quality control; SPM, suspected pleural malignancy.